Bank of Montreal
CERE

Bank of Montreal’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bank of Montreal’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-96,014
Closed -$2.18M – 4376
2023
Q3 		$2.18M Buy
+96,014
New +$2.4M ﹤0.01% 1655
2022
Q3 		– Sell
-131,970
Closed -$3.7K – 4490
2022
Q2 		$3.7K Buy
+131,970
New +$3.75M ﹤0.01% 1578

Other funds holding CERE

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Bank of Montreal's CERE Position: Q4 2023 in Review

Bank of Montreal sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q4 2023, closing a stake of 96,014 shares — an estimated $2.18M sold.

Bank of Montreal first reported a position in CERE in Q2 2022 and held it in 2 quarters. The position peaked at $2.18M in Q3 2023. 195 funds tracked by Wall St. Rank hold CERE as of Q4 2023.

  • Bank of Montreal reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Bank of Montreal sold 96,014 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q4 2023, an estimated $2.18M.
  • Bank of Montreal first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Bank of Montreal's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $2.18M in Q3 2023.
  • 195 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q4 2023.

Based on Bank of Montreal's 13F filing for Q4 2023, filed 8 Feb 2024.